Solventum Corporation
As of Oct 23, 2026 close
- Market cap
- $14.80B
- P/E (TTM)
- 10.32
- Forward P/E
- 5.34
- Dividend yield
- -
- 52-week range
- $62.38$94.16
- Volume (live)
- -
- Avg. volume (3M)
- 928.79K
Solventum (SOLV) Stock Price & Financial Analysis
Solventum Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $84.81 - $87.27 |
|---|---|
| 52-Week High | $94.16 |
| 52-Week Low | $62.38 |
| Open | $86.92 |
| Volume (last close) | 1.66M |
| Average Volume (3M) | 928.79K |
| Revenue (TTM) | 8.31B |
|---|---|
| Net Income (TTM) | 1.43B |
| Free Cash Flow (TTM) | -118.00M |
| EPS (TTM) | $8.20 |
| Profit Margin | 17.26% |
| Operating Margin | 24.59% |
| Return on Equity (ROE) | 29.88% |
| Debt to Equity | 1.06 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 14.80B |
|---|---|
| Shares Outstanding | 173.30M |
| P/E Ratio (TTM) | 10.32 |
| Forward P/E | 5.34 |
| Price to Sales (P/S) | 1.78 |
| Price to Book (P/B) | 3.08 |
| EV/EBITDA | 19.27 |
| 50-Day MA | $88.50 |
|---|---|
| 200-Day MA | $78.32 |
| 1-Year Change | +21.00% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Solventum at a Glance
As of the Oct 23, 2026 close, Solventum (SOLV) has a market capitalization of $14.80B. The stock trades at 10.3× trailing earnings, 5.3× forward earnings and 1.8× sales. Over the trailing twelve months it earned $1.43B on revenue of $8.31B (a 17.3% profit margin) and burned $118.00M of free cash flow. Revenue fell 0.9% year over year.
As of its latest reported balance sheet, it holds $403.00M in cash and securities against $5.08B of debt, a net debt position of $4.68B.
Solventum does not currently pay a dividend.
The share price is up 21.0% over the past year. At $85.41 (the Oct 23, 2026 close) it sits within its 52-week range of $62.38 to $94.16, above its 200-day moving average of $78.32.
Based on 12 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $98.50, 15.3% above the Oct 23, 2026 close.
Frequently Asked Questions About Solventum
What is the current stock price for SOLV?
As of the Oct 23, 2026 close, SOLV stock trades at $85.41. The 52-week range is $62.38–$94.16, with a day range of $84.81–$87.27.
What is the P/E ratio for SOLV?
As of the Oct 23, 2026 close, Solventum's trailing twelve-month (TTM) P/E ratio is 10.3, meaning investors pay $10.3 for every $1 of annual earnings. The forward P/E is 5.3, reflecting analyst expectations for future earnings. Solventum operates in the Healthcare sector.
Does SOLV pay dividends?
Solventum does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.
What do analysts recommend for SOLV?
Based on ratings from 12 professional analysts over the last 90 days, the consensus for SOLV is Buy. The average 12-month price target is $98.50, a 15.3% upside from the Oct 23, 2026 close of $85.41.
What is the market cap of SOLV?
As of the Oct 23, 2026 close, Solventum's market capitalization is $14.80B, classifying it as a large-cap company. Solventum operates in the Healthcare sector within the Medical Instruments & Supplies industry.